040-000-352 Escin, CAS 6805-41-0

SKU: 040-000-352 Category:
Get A Quote






  I would like to join the mailing list to receive updates from Stanford Chemicals.
*: e-mail address with your company's domain name is preferred. Otherwise, we may not be able to process your inquiry.

Synonym Aescin
Keywords Anti-inflammation, anti-vasoconstrictor, anti- vasoprotective
Related products  Hydrocortisone Hemisuccinate Sodium Salt, Hydrocortisone Acetate, Vinpocetine
Description

Description

Escin Specifications

Product Name Escin
CAS Registry Number 11072-93-8 β-Aescin

6805-41-0  Aescin

Molecular Formula C55H86O24
Molecular Weight 1131.269 g/mol
Purity 99.0%
Appearance White powder
Package 1kg-25kg
Shelf life 2 years
Functions Anti-inflammation, anti-vasoconstrictor, and vasoprotective effects

Escin Description

Aescin or escin is derived from horse chestnut extracts. It can promote the synthesis of collagen, repair damaged skin, and can effectively moisturize. It is rich in flavonoids, has natural and powerful anti-aging and anti-wrinkle effects, can improve the blood circulation of some eye skins, and can also eliminate cellulite, and has some effects on dark circles and bags under the eyes.

Escin is an endothelium-protective drug that is extracted from Aesculus hippocastanum seeds.

escin

Escin Benefits

  1. Well-known benefits for venous insufficiency and related conditions
  2. Have many potential positive pharmacological effects on the skin, can be effective anti-inflammatory and anti-aging
  3. Can reduce capillary fragility, thus helping to prevent fluid leakage into surrounding tissues, thus preventing swelling
  4. Horse chestnut extract has the highest “reactive oxygen” scavenging capacity. Such extracts are stronger antioxidants than vitamin E and also have a strong cytoprotective effect

Escin Application

  • Pharmaceutical ingredients of eye drops and intravenous fluid

Reference:

  1. Pittler, Max H.; Ernst, Edzard (2012-11-14). “Horse chestnut seed extract for chronic venous insufficiency”. The Cochrane Database of Systematic Reviews. 11: CD003230.
  2. Carrasco OF, Vidrio H (July 2007). “Endothelium protectant and contractile effects of the antivaricose principle escin in rat aorta”. Vascul. Pharmacol. 47 (1): 68–73.
  3. Berti F, Omini C, Longiave D (August 1977). “The mode of action of aescin and the release of prostaglandins”. Prostaglandins. 14 (2): 241–249.